Defining and predicting functional outcome in schizophrenia and schizophrenia spectrum disorders

Schizophrenia Research

Volumn 113, Issue 2-3, 2009, Pages 210-217

  Schennach Wolff, Rebecca ^a   Jäger, Markus ^a   Seemüller, Florian ^a   Obermeier, Michael ^a   Messer, Thomas ^b   Laux, Gerd ^c   Pfeiffer, Herbert ^d   Naber, Dieter ^e   Schmidt, Lutz G ^f   Gaebel, Wolfgang ^g   Huff, Wolfgang ^h   Heuser, Isabella ⁱ   Maier, Wolfgang ^j   Lemke, Matthias R ^k   Rüther, Eckart ^l   Buchkremer, Gerd ^m   Gastpar, Markus ⁿ   Möller, Hans Jürgen ^a   Riedel, Michael ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL AUGSBURG   (Germany)

^c Inn Salzach Hospital   (Germany)

^d KLINIKUM MÜNCHEN OST   (Germany)

^e UNIVERSITY OF HAMBURG   (Germany)

^f JOHANNES GUTENBERG UNIVERSITY   (Germany)

^g HEINRICH HEINE UNIVERSITY   (Germany)

^h UNIVERSITY OF COLOGNE   (Germany)

ⁱ CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^j UNIVERSITY OF BONN   (Germany)

^k Protestant Hospital Alsterdorf   (Germany)

^l UNIVERSITY OF GÖTTINGEN   (Germany)

^m UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

ⁿ UNIVERSITY OF DUISBURG ESSEN   (Germany)

more..

Author keywords

Prediction; Quality of life; Remission; Schizophrenia; Social functioning

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BRIEF PSYCHOTIC DISORDER; DELUSION; DISEASE DURATION; EMPLOYMENT STATUS; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; QUALITY OF LIFE; REMISSION; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; SUICIDE;

ADULT; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; OUTCOME ASSESSMENT (HEALTH CARE); PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RECURRENCE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; ROC CURVE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 68249132562     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2009.05.032     Document Type: Article

References (62)

1. Addington J., and Addington D. Premorbid functioning, cognitive functioning, symptoms and outcome in schizophrenia. J. Psychiatry Neurosci. 18 (1993) 18-23
2. Addington J., Penn D., Woods S.W., Addington D., and Perkins D.O. Social functioning in individuals at clinical high risk for psychosis. Schizophr. Res. 99 (2008) 119-124
3. Agid O., Kapur S., Arenovich T., and Zipursky R.B. Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected. Arch. Gen. Psychiatry 60 (2003) 1228-1235
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd Rev. ed. (1987), American Psychiatric Association, Washington DC
5. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fourth edition (1994), American Psychiatric Association, Washington DC
6. Andreasen N.C., Carpenter W.T., Kane J.M., Lasser R.A., Marder S.R., and Weinberger D.R. Remission in schizophrenia: proposed criteria and rationale for consensus. Am. J. Psychiatry 162 (2005) 441-449
7. Babyak M.A. What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models. Psychosom. Med. 66 (2004) 411-421
8. Bachmann S., Bottmer C., and Schroder J. One-year outcome and its prediction in first-episode schizophrenia-a naturalistic study. Psychopathology 41 (2008) 115-123
9. Beitinger R., Lin J., Kissling W., and Leucht S. Comparative remission rates of schizophrenic patients using various remission criteria. Prog. Neuro-psychopharmacol. Biol. Psychiatry. 32 (2008) 1643-1651
10. Blom M.B., Spinhoven P., Hoffman T., Jonker K., Hoencamp E., Haffmans P.M., and van D.R. Severity and duration of depression, not personality factors, predict short term outcome in the treatment of major depression. J. Affect. Disord. 104 (2007) 119-126
11. Boden R., Sundstrom J., Lindstrom E., and Lindstrom L. Association between symptomatic remission and functional outcome in first-episode schizophrenia. Schizophr. Res. 107 (2009) 232-237
12. Breiman L., Friedman H.J., Olshen R.A., and Stone C.J. Classification and Regression Trees Wadsworth International Group, Belmont, CA (1984)
13. Brekke J., Kay D.D., Lee K.S., and Green M.F. Biosocial pathways to functional outcome in schizophrenia. Schizophr. Res. 80 (2005) 213-225
14. Ciudad A., Alvarez E., Bobes J., San L., Polavieja P., and Gilaberte I. Remission in schizophrenia: Results from a 1-year follow-up observational study. Schizophr. Res. 108 (2009) 214-222
15. Clark L.A., and Pregibon D. Tree-based models. In: Chambers J., and Hastie T. (Eds). Statistical Models (1992), Wadsworth & Books/Cole Advanced Books & Software, Pacific Grove, CA
16. Cording C. Conceptual aspects in development and implementation of basic psychiatric documentation. Psychiatr. Prax. 25 (1998) 175-178
17. Correll C.U., Malhotra A.K., Kaushik S., McMeniman M., and Kane J.M. Early prediction of antipsychotic response in schizophrenia. Am. J. Psychiatry 160 (2003) 2063-2065
18. D'Eramo K.S., Prinstein M.J., Freeman J., Grapentine W.L., and Spirito A. Psychiatric diagnoses and comorbidity in relation to suicidal behavior among psychiatrically hospitalized adolescents. Child Psychiatry Hum. Dev. 35 (2004) 21-35
19. De H.M., van W.R., Wampers M., Kane J., Van O.J., and Peuskens J. Remission criteria for schizophrenia: evaluation in a large naturalistic cohort. Schizophr. Res. 92 (2007) 68-73
20. Dickerson F., Boronow J.J., Ringel N., and Parente F. Social functioning and neurocognitive deficits in outpatients with schizophrenia: a 2-year follow-up. Schizophr. Res. 37 (1999) 13-20
21. Eaton W.W., Mortensen P.B., Herrman H., Freeman H., Bilker W., Burgess P., and Wooff K. Long-term course of hospitalization for schizophrenia: part I. Risk for rehospitalization. Schizophr. Bull. 18 (1992) 217-228
22. Emsley R.A., Oosthuizen P.P., Joubert A.F., Roberts M.C., and Stein D.J. Depressive and anxiety symptoms in patients with schizophrenia and schizophreniform disorder. J. Clin. Psychiatry 60 (1999) 747-751
23. Emsley R., Oosthuizen P.P., Kidd M., Koen L., Niehaus D.J., and Turner H.J. Remission in first-episode psychosis: predictor variables and symptom improvement patterns. J. Clin. Psychiatry 67 (2006) 1707-1712
24. Emsley R., Chiliza B., and Schoeman R. Predictors of long-term outcome in schizophrenia. Curr. Opin. Psychiatry 21 (2008) 173-177
25. Gilmer W.S., Gollan J.K., Wisniewski S.R., Howland R.H., Trivedi M.H., Miyahara S., Fleck J., Thase M.E., Alpert J.E., Nierenberg A.A., Warden D., Fava M., and Rush A.J. Does the duration of index episode affect the treatment outcome of major depressive disorder? A STAR*D report. J. Clin. Psychiatry 69 (2008) 1246-1256
26. Green M.F., and Nuechterlein K.H. Should schizophrenia be treated as a neurocognitive disorder?. Schizophr. Bull. 25 (1999) 309-319
27. Haro J.M., Novick D., Suarez D., Ochoa S., and Roca M. Predictors of the course of illness in outpatients with schizophrenia: a prospective three year study. Prog. Neuro-psychopharmacol. Biol. Psychiatry. 32 (2008) 1287-1292
28. Harrison G., Hopper K., Craig T., Laska E., Siegel C., Wanderling J., Dube K.C., Ganev K., Giel R., an der H.W., Holmberg S.K., Janca A., Lee P.W., Leon C.A., Malhotra S., Marsella A.J., Nakane Y., Sartorius N., Shen Y., Skoda C., Thara R., Tsirkin S.J., Varma V.K., Walsh D., and Wiersma D. Recovery from psychotic illness: a 15- and 25-year international follow-up study. Br. J. Psychiatry 178 (2001) 506-517
29. Harvey P.D., and Bellack A.S. Toward a terminology for functional recovery in schizophrenia: is functional remission a viable concept?. Schizophr. Bull. 35 2 (2009) 300-306
30. Helldin L., Kane J.M., Karilampi U., Norlander T., and Archer T. Remission in prognosis of functional outcome: a new dimension in the treatment of patients with psychotic disorders. Schizophr. Res. 93 (2007) 160-168
31. Hintikka U., Marttunen M., Pelkonen M., Laukkanen E., Viinamaki H., and Lehtonen J. Improvement in cognitive and psychosocial functioning and self image among adolescent inpatient suicide attempters. BMC Psychiatry 6 (2006) 58
32. Hofer A., Baumgartner S., Edlinger M., Hummer M., Kemmler G., Rettenbacher M.A., Schweigkofler H., Schwitzer J., and Fleischhacker W.W. Patient outcomes in schizophrenia I: correlates with sociodemographic variables, psychopathology, and side effects. Eur. Psychiatr. 20 (2005) 386-394
33. Hofer A., Rettenbacher M.A., Widschwendter C.G., Kemmler G., Hummer M., and Fleischhacker W.W. Correlates of subjective and functional outcomes in outpatient clinic attendees with schizophrenia and schizoaffective disorder. Eur. Arch. Psychiatry Clin. Neurosci. 256 (2006) 246-255
34. Hoffmann H., Kupper Z., Zbinden M., and Hirsbrunner H.P. Predicting vocational functioning and outcome in schizophrenia outpatients attending a vocational rehabilitation program. Soc. Psychiatry Psychiatr. Epidemiol. 38 (2003) 76-82
35. Honkonen T., Stengard E., Virtanen M., and Salokangas R.K. Employment predictors for discharged schizophrenia patients. Soc. Psychiatry Psychiatr. Epidemiol. 42 (2007) 372-380
36. Kay S.R., Opler L.A., and Lindenmayer J.P. Reliability and validity of the positive and negative syndrome scale for schizophrenics. Psychiatry Res. 23 (1988) 99-110
37. Lambert M., Schimmelmann B.G., Naber D., Schacht A., Karow A., Wagner T., and Czekalla J. Prediction of remission as a combination of symptomatic and functional remission and adequate subjective well-being in 2960 patients with schizophrenia. J. Clin. Psychiatry 67 (2006) 1690-1697
38. Lasser R.A., Bossie C.A., Gharabawi G.M., and Kane J.M. Remission in schizophrenia: Results from a 1-year study of long-acting risperidone injection. Schizophr. Res. 77 (2005) 215-227
39. Lasser R.A., Nasrallah H., Helldin L., Peuskens J., Kane J., Docherty J., and Tronco A.T. Remission in schizophrenia: applying recent consensus criteria to refine the concept. Schizophr. Res. 96 (2007) 223-231
40. Leucht S., Busch R., Kissling W., and Kane J.M. Early prediction of antipsychotic nonresponse among patients with schizophrenia. J. Clin. Psychiatry 68 (2007) 352-360
41. Lindstrom L.H. Clinical and biological markers for outcome in schizophrenia: a review of a longitudinal follow-up study in Uppsala schizophrenia research project. Neuropsychopharmacology 14 (1996) 23S-26S
42. Lindstrom E., Eberhard J., and Levander S. Five-year follow-up during antipsychotic treatment: efficacy, safety, functional and social outcome. Acta Psychiatr. Scand., Suppl. (2007) 5-16
43. Marwaha S., and Johnson S. Schizophrenia and employment - a review. Soc. Psychiatry Psychiatr. Epidemiol. 39 (2004) 337-349
44. Nasrallah H.A., Targum S.D., Tandon R., McCombs J.S., and Ross R. Defining and measuring clinical effectiveness in the treatment of schizophrenia. Psychiatr. Serv. 56 (2005) 273-282
45. Oosthuizen P., Emsley R.A., Roberts M.C., Turner J., Keyter L., Keyter N., and Torreman M. Depressive symptoms at baseline predict fewer negative symptoms at follow-up in patients with first-episode schizophrenia. Schizophr. Res. 58 (2002) 247-252
46. Patterson D.A., and Lee M.S. Field trial of the Global Assessment of Functioning Scale-Modified. Am. J. Psychiatry 152 (1995) 1386-1388
47. Peuskens J., Kaufman L., and Van V.B. Analysis of resolution criteria in patients with schizophrenia treated with olanzapine for an acute psychotic episode. Schizophr. Res. 95 (2007) 169-173
48. Pukrop R., Schlaak V., Moller-Leimkuhler A.M., Albus M., Czernik A., Klosterkotter J., and Moller H.J. Reliability and validity of Quality of Life assessed by the Short-Form 36 and the Modular System for Quality of Life in patients with schizophrenia and patients with depression. Psychiatry Res. 119 (2003) 63-79
49. Rogers E.S., Anthony W.A., Cohen M., and Davies R.R. Prediction of vocational outcome based on clinical and demographic indicators among vocationally ready clients. Community Ment. Health J. 33 (1997) 99-112
50. Roy-Byrne P., Dagadakis C., Unutzer J., and Ries R. Evidence for limited validity of the revised Global Assessment of Functioning Scale. Psychiatr. Serv. 47 (1996) 864-866
51. Salokangas R.K. Living situation, social network and outcome in schizophrenia: a five-year prospective follow-up study. Acta Psychiatr. Scand. 96 (1997) 459-468
52. San L., Ciudad A., Alvarez E., Bobes J., and Gilaberte I. Symptomatic remission and social/vocational functioning in outpatients with schizophrenia: prevalence and associations in a cross-sectional study. Eur. Psychiatr. 22 (2007) 490-498
53. Ascher-Svanum H., Nyhuis A.W., Faries D.E., Kinon B.J., Baker R.W., and Shekhar A. Clinical, functional, and economic ramifications of early nonresponse to antipsychotics in the naturalistic treatment of schizophrenia. Schizophr. Bull. 34 (2008) 1163-1171
54. Sethuraman G., Taylor C.C., Enerson M., and Dunayevich E. A retrospective comparison of cumulative time spent in remission during treatment with olanzapine or risperidone among patients with schizophrenia. Schizophr. Res. 79 (2005) 337-340
55. Siegel S.J., Irani F., Brensinger C.M., Kohler C.G., Bilker W.B., Ragland J.D., Kanes S.J., Gur R.C., and Gur R.E. Prognostic variables at intake and long-term level of function in schizophrenia. Am. J. Psychiatry 163 (2006) 433-441
56. Tabares-Seisdedos R., Balanza-Martinez V., Sanchez-Moreno J., Martinez-Aran A., Salazar-Fraile J., Selva-Vera G., Rubio C., Mata I., Gomez-Beneyto M., and Vieta E. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up. J. Affect. Disord. 109 (2008) 286-299
57. Tunis S.L., Croghan T.W., Heilman D.K., Johnstone B.M., and Obenchain R.L. Reliability, validity, and application of the Medical Outcomes Study 36-item Short-Form Health Survey (SF-36) in schizophrenic patients treated with olanzapine versus haloperidol. Med. Care 37 (1999) 678-691
58. Velligan D.I., Mahurin R.K., Diamond P.L., Hazleton B.C., Eckert S.L., and Miller A.L. The functional significance of symptomatology and cognitive function in schizophrenia. Schizophr. Res. 25 (1997) 21-31
59. Ware J.E. SF-36 health survey update. Spine 25 (2000) 3130-3139
60. Ware J.E., and Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med. Care 30 (1992) 473-483
61. Weinstein M.C., and Fineberg H.V. Clinical Decisions Analysis (1980), WB Saunders, Philadelphia, PA
62. Wittorf A., Wiedemann G., Buchkremer G., and Klingberg S. Prediction of community outcome in schizophrenia 1 year after discharge from inpatient treatment. Eur. Arch. Psychiatry Clin. Neurosci. 258 (2008) 48-58